US President Trump imposed 200% tariff on pharmaceuticals affecting US drug prices and supply chain, but analysts say it may ...

In this article, you’ll find some of the top content that was published on LCGC this week, including an ASMS 2025 retrospective and an overview of microplastic research.

While a one-stop shop still has its advantages, sponsor companies and CDMOs are starting to see each other not as ...

The second quarter of 2025 was a period of dynamic evolution within the biotech and pharma sectors. Critical factors like ...

The pharmaceutical industry’s move toward increased U.S.-based manufacturing is changing the landscape of career ...

LLY's explosive growth from Mounjaro and Zepbound outpaces MRK's Keytruda-led gains, despite valuation concerns.

Johnson & Johnson stands alone as a leader across the major healthcare industries. It maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that ...

The company has plans to make further acquisitions to enter newer product segments and geographies and expand market share.

What is the flow cytometry market?Flow cytometry is a technique employed in laboratories to analyze the physical and chemical ...

With EUR 12.9 billion in direct investments and 125,000 jobs generated, France ranks as the third largest foreign investor in ...

Trump announced significant increases to import tariffs: a 50% tariff on copper and a planned 200% tariff on pharmaceuticals, the latter to take effect after a one-year delay.